ALTIMMUNE, INC. Proceeds from Long-Term Debt Issued
ALTIMMUNE, INC. (ALT) reported Proceeds from Long-Term Debt Issued of $35.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-03-06
- ALTIMMUNE, INC. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $20.00M.
- ALTIMMUNE, INC. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00.
- ALTIMMUNE, INC. proceeds from issuance of long-term debt for the quarter ending 2012-06-30 was $0.00.
- ALTIMMUNE, INC. proceeds from issuance of long-term debt for the quarter ending 2012-03-31 was $2.50M.
- ALTIMMUNE, INC. proceeds from issuance of long-term debt for fiscal 2025 was $35.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $20.00M derived: sum of 2 quarters · filed 2026-03-06 | $35.00M 10-K · filed 2026-03-06 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.00M 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $15.00M 10-Q · filed 2025-08-12 | |||
| 2013-06-30 | -$250.00K 10-Q · filed 2013-08-08 | |||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.50M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $2.50M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |